Suchergebnisse - "Usmani, Saad Z"

PubPharm (308)

11

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

enthalten in: Blood advances | 2024

von Firestone, R. | McAvoy, D. | Shekarkhand, T. | +23

12

SOHO State of the Art Updates and Next Questions : Will CAR-T Replace ASCT in NDMM

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Jurgens, E. | Usmani, S.

13

Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study

enthalten in: British journal of haematology | 2024

von Nooka, A. | Kaufman, J. | Rodriguez, C. | +16

14

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

15

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Martin, T. | Moreau, P. | Usmani, S. | +20

16

Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study

enthalten in: Leukemia | 2024

von Castro, F. | Parikh, R. | Eustaquio, J. | +5

UpdateOf: medRxiv. 2023 Sep 23;:. - PMID 37790335

17

Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population

enthalten in: Blood advances | 2024

von Joseph, J. | Hillengass, J. | Tang, L. | +6

18

Daratumumab for patients with myeloma with early or late relapse after initial therapy : subgroup analysis of CASTOR and POLLUX

enthalten in: Blood advances | 2024

von Spencer, A. | Moreau, P. | Mateos, M. | +17

19

Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma : TAURUS Chart Review Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Gordan, L. | Tan, C. | Vescio, R. | +12

20

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

enthalten in: Blood advances | 2024

von Shah, U. | Moshier, E. | Derkach, A. | +20

CommentIn: Blood Adv. 2024 Jan 9;8(1):234-235. - PMID 38194241